关键词: Chronic myeloid leukemia Nilotinib Platelets Ponatinib Tyrosine kinase inhibitor Vascular adverse events
来 源:
DOI:10.1186/s40959-015-0008-5
PDF(Sci-hub)
PDF(Pubmed)